Headline
The latest stories from AHA Today.
Fourteen leading U.S. drug companies from 2016 to 2020 spent $577 billion on stock buybacks and dividends, $56 billion more than they spent on research and development over the same period, according to a report released by the House Committee on Oversight and Reform.
The AHA expressed support for the Protecting Rural Telehealth Access Act (S. 1988), legislation that would make permanent several telehealth flexibilities provided under the ongoing COVID-19 public health emergency.
As urged by the AHA, the Occupational Safety and Health Administration said it will extend to Aug. 20 the deadline for submitting comments on its COVID-19 health care emergency temporary standard.
President Biden signed an executive order establishing a “whole-of-government” effort to promote competition in the American economy.
The National Institutes of Health today in its Annual Report to the Nation on the Status of Cancer highlighted an overall decline in cancer death rates among men and women from all racial and ethnic groups in the United States.
To mark National Minority Mental Health Awareness Month, the Centers for Disease Control and Prevention shared new resources as part of its Hear Her campaign, which seeks to raise awareness of potentially life-threatening warning signs during and after pregnancy and improve communication between…
The National Institutes of Health released a study suggesting one in every four COVID-19 deaths in U.S. hospitals may have been attributed to the dire strain that surges in caseloads placed on hospitals during the pandemic.
The Department of Health and Human Services withdrew requests for proposals on ways individuals could import prescription drugs from other countries where they are typically cheaper and companies could “reimport” insulin to sell at a lower price.
The Commonwealth Fund reported that approximately 279,000 lives have been saved through the U.S.’s vaccination efforts, with 1.25 million avoiding hospitalization.
Responding last month to an AHA letter, the Centers for Medicare & Medicaid Services said it will continue to remain flexible in its approach to surveys if a hospital experiences a COVID-19 surge.